The Latest Cardiac and Vascular News
COPENHAGEN, Denmark, Aug. 15, 2023 /PRNewswire/ — CathVision, a medical technology company developing innovative electrophysiology solutions designed to enhance clinical decision making in the EP lab, today announced the FDA clearance and commercial availability of the PVI AnalyzerTM and Signal ComplexityTM algorithms. These algorithms are part of the CARDIALYTICSTM suite of artificial intelligence-powered analytics integrated into […]
COPENHAGEN, Denmark, July 18, 2023 /PRNewswire/ — CathVision, a medical technology company developing innovative electrophysiology solutions designed to support clinical decision making in the EP lab, today announced its most recent financing round of $9 million from investors. CathVision secures $9 Million in funding to advance commercial operations driving adoption of the ECGenius™ System The […]
Series of Clinical Studies Highlight Advantages of ECGenius System and CARDIALYTICS Suite of Algorithms COPENHAGEN, Denmark, April 17, 2023 /PRNewswire/ — CathVision, a medical technology company developing innovative electrophysiology solutions to enhance clinical decision-making in the EP lab, today announced initial patient enrollment of a follow-on clinical study to demonstrate the value […]
ECGenius System & CARDIALYTICS Suite Recognized as Critical to the Evolution of Electrophysiology COPENHAGEN, Denmark, March 28, 2023 /PRNewswire/ — CathVision, a medical technology company developing innovative electrophysiology solutions designed to enhance clinical decision-making in the EP lab, is proud to announce the achievement of significant milestones demonstrating both the clinical and commercial […]
Study Advances Efforts to Launch CARDIALYTICS Suite of Analytic Tools COPENHAGEN, Denmark, Nov. 2, 2022 /PRNewswire/ — CathVision, a medical technology company developing innovative electrophysiology solutions to enhance clinical decision-making in the EP lab, today announced the investigation of the Signal Complexity™ algorithm designed to visualize and quantify atrial fibrillation (AF) complexity parameters in […]
Funding Will Accelerate Commercialization of the ECGenius™ System and Expand Development of Analytic Modules COPENHAGEN, Denmark, Aug. 17, 2022 /PRNewswire/ — CathVision, a medical technology company developing innovative electrophysiology solutions designed to enhance clinical decision making in the EP lab, today announced the company has secured $7.2 million in funding from existing investors. The financing […]
ECGenius Sets a New Standard for ECG Signal Detection, Interpretation and Therapy Support COPENHAGEN, Denmark , May 4, 2022 /PRNewswire/ — CathVision, a medical technology company developing innovative electrophysiology solutions designed to enhance clinical decision making in the EP lab, today announced the FDA 510(k) clearance of the ECGenius EP Recording System. ECGenius, the […]
University of Vermont Medical Center Initiates Evaluation of the ECGenius System as CathVision Prepares for U.S. Launch COPENHAGEN, Denmark, April 26, 2022 /PRNewswire/ — CathVision, a medical technology company developing innovative electrophysiology solutions designed to guide and enhance cardiac ablation therapy through the acquisition of low-noise, high-fidelity electrograms, today announced the completion of patient […]
Researchers to Examine Efficacy of Using AI Algorithm to Confirm Pulmonary Vein Isolation COPENHAGEN, Denmark and MINNETONKA, Minn., Oct. 26, 2021 /PRNewswire/ — CathVision, a medical technology company developing innovative electrophysiology solutions in EP recording technology, today announced the first patient enrollments in the PVISION multicenter clinical study. The newly launched trial will investigate the […]
COPENHAGEN, Denmark, March 16, 2021 /PRNewswire/ — CathVision ApS, a medical device company developing a novel artificial intelligence therapeutic platform for cardiac electrophysiology procedures, is announcing a change to its Board of Directors. Meghna Eichelberger, Partner and Associate Director of Medical Technologies, at The Boston Consulting Group (BCG), has joined CathVision’s Board […]
